T cells and autoimmune kidney disease. (Q39175811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

T cells and autoimmune kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Sean J Bradley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

George C Tsokos

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

English

0 references

publication date

13 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

5 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

329-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Biologics for the treatment of autoimmune renal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Advances in human antiglomerular basement membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Basic and translational concepts of immune-mediated glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The immune system and kidney disease: basic concepts and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Neutrophils: game changers in glomerulonephritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The role of neutrophils and NETosis in autoimmune and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Connective tissue diseases: Mitochondria drive NETosis and inflammation in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Inflammatory manifestations in chronic granulomatous disease (CGD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

What is damaging the kidney in lupus nephritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Plasma cells as an innovative target in autoimmune disease with renal manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Memory γδ T Cells-Newly Appreciated Protagonists in Infection and Immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Role of gamma-delta (γδ) T cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Chaperonin-containing T-complex Protein 1 Subunit ζ Serves as an Autoantigen Recognized by Human Vδ2 γδ T Cells in Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Double-negative regulatory T cells: non-conventional regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Elevated double negative T cells in pediatric autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Pro-inflammatory self-reactive T cells are found within murine TCR-αβ(+) CD4(-) CD8(-) PD-1(+) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The Th17 immune response in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Proinflammatory T helper type 17 cells are effective B-cell helpers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Renal IL-17 expression in human ANCA-associated glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Plasticity of Th17 Cells in Autoimmune Kidney Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Follicular helper T cells in immunity and systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T follicular helper cells in human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CXCR3+ Regulatory T Cells Control TH1 Responses in Crescentic GN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Adaptive immune regulation in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Regulatory T cells in immune-mediated renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Current status of tolerance in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Empowering Regulatory T Cells in Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

A Distinct Function of Regulatory T Cells in Tissue Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The emerging role of resident memory T cells in protective immunity and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Various roles of Th cytokine mRNA expression in different forms of glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17 promotes murine lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Targeting IL-17 and IL-23 in Immune Mediated Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The biological functions of T helper 17 cell effector cytokines in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CXCL5 drives neutrophil recruitment in TH17-mediated GN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-17 in systemic lupus erythematosus: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T cells in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Treatment with anti-interleukin 23 antibody ameliorates disease in lupus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Lupus Nephritis IgG Induction of Calcium/Calmodulin-Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Induction and molecular signature of pathogenic TH17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Oxalate stimulates IL-6 production in HK-2 cells, a line of human renal proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T follicular helper cells in space-time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-6 in renal disease and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Effect ofIL-6C-572G polymorphism on idiopathic membranous nephropathy risk in a han chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

ICER is requisite for Th17 differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

tTregs, pTregs, and iTregs: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Regulatory B cells mediate tolerance to apoptotic self in health: implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Regulatory role of natural killer T cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL10 in Lupus Nephritis: Detection and relationship with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Low-Dose IL-2 in the Treatment of Lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Loss of immune tolerance to IL-2 in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Restoring Regulatory T Cells in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Reduced Expression of TCR Zeta Is Involved in the Abnormal Production of Cytokines by Peripheral T Cells of Patients with Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T cell CD3ζ deficiency enables multiorgan tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Rho Kinases in Health and Disease: From Basic Science to Translational Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

PP2A: The Wolf in Sheep's Clothing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Phosphatase PP2A is requisite for the function of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The protein phosphatase 2A regulatory subunit B56γ mediates suppression of T cell receptor (TCR)-induced nuclear factor-κB (NF-κB) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

cAMP responsive element modulator: a critical regulator of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Immune Cell Metabolism in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Intersection of mTOR and STAT signaling in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Lupus-prone strains vary in susceptibility to antibody-mediated end organ disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The Tuberin/mTOR Pathway Promotes Apoptosis of Tubular Epithelial Cells in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Autoantibodies in renal diseases - clinical significance and recent developments in serological detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

T cells and IL-17 in lupus nephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Predominance of Th1 immune response in diffuse proliferative lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Function of the Th17/interleukin-17A immune response in murine lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Role of IL-10 in the progression of kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

The Ca2+/Calmodulin-dependent Kinase Type IV Is Involved in the CD5-mediated Signaling Pathway in Human T Lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.34

Rho kinase inhibition in diabetic kidney disease

31 March 2020

1 reference

12 December 2020

The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model.

1 reference

12 December 2020

Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.

1 reference

12 December 2020

Calcium- and calmodulin-dependent PMA-activation of the CD44 adhesion molecule

1 reference

12 December 2020

Immunoregulation of NKT Cells in Systemic Lupus Erythematosus

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2017.34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28287110%20AND%20SRC:MED&resulttype=core&format=json